Through a collaboration with Evolent — a health technology company focused on managing complex care — Florida Blue achieved a 40% drop in hospital and emergency room visits for Medicare Advantage members with cancer, according to a Jan. 14 news release.
The partnership has been in place since 2021 and allows members to access care navigators and digital tools for ongoing support. The initiative has a 95% satisfaction rate among patients and caregivers.
The program also leverages the digital platform Careology to track symptoms, remind patients of appointments and medications, send updates to the care team and funnel advice outside of office visits.
“This innovative approach helps members and their families better manage their cancer care, with greater confidence and clarity, so they can focus on their health, loved ones and quality of life,” Florida Blue Medicare Chief Medical Officer Thomas Graf, MD, said in the release.
Evolent has also worked with Centene on oncology specialty care. In 2024, Elevance Health expressed interest in acquiring the health tech company, but ultimately reconsidered.
